Colchicine Tablet, Film Coated
Product Images NDC 0378-1086

4 FDA label images from Mylan Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Colchicine (NDC 0378-1086). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dosing Calculation (Image 01)

Dosing Calculation (Image 01)
The image shows a formula used to calculate creatinine clearance (Clcr), incorporating age in years, body weight in kilograms, serum creatinine in mg/dL, and an adjustment factor of 0.85 for female patients.*
FDA Label Image

Colchicine Structural Formula (Image 02)

Colchicine Structural Formula (Image 02)
Chemical structure of Colchicine showing the arrangement of atoms and molecular components characteristic to this active ingredient.*
FDA Label Image

Colchicine Tablets 0.6 mg Bottle Label (Image 03)

Colchicine Tablets 0.6 mg Bottle Label (Image 03)
The packaging label for Colchicine Tablets USP, 0.6 mg, by Mylan Pharmaceuticals Inc. It shows the tablet is film-coated and oral. The label includes the NDC 0378-1086-93, a picture of a single oval tablet marked "CC 2," and indicates a 30-tablet count. Usage and storage instructions are printed, noting Rx only status and safety precautions.*
FDA Label Image

Figure 1: Pain Relief On Low And High Doses Of Colchicine Tablets And Placebo (cumulative) (Image 04)

Figure 1: Pain Relief On Low And High Doses Of Colchicine Tablets And Placebo (cumulative) (Image 04)
A line graph comparing the percentage of patients improved versus the percentage improvement for Colchicine Tablets at low dose (1.8 mg), high dose (4.8 mg), and placebo. The y-axis shows the % of patients improved and the x-axis shows % improvement, with three lines representing each group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.